These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30772785)

  • 1. Thiosemicarbazone and thiazolylhydrazones of 1-indanone: As a new class of nonacidic anti-inflammatory and antiplatelet aggregation agents.
    Nazim U; Ahmed M; Ali B; Khan KM; Ali M; Kobarfard F; Arshia -; Ayatollahi SA; Hassan A; Jabeen A; Faheem A
    Pak J Pharm Sci; 2019 Jan; 32(1):15-19. PubMed ID: 30772785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
    Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
    Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.
    Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
    Liu XJ; Shi TE; Wang X; Wei TT; Meng X
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
    Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
    ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
    Liu X; Chen X; Qiu K; Zhang Z
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors.
    Xie Z; Zhao L; Ding X; Kong Y; Li Z
    Future Med Chem; 2018 Feb; 10(4):367-378. PubMed ID: 29380625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 1-indanone thiosemicarbazone derivatives active against BVDV.
    Finkielsztein LM; Castro EF; Fabián LE; Moltrasio GY; Campos RH; Cavallaro LV; Moglioni AG
    Eur J Med Chem; 2008 Aug; 43(8):1767-73. PubMed ID: 18063227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
    Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
    Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.
    Marcinkowska M; Kotańska M; Zagórska A; Śniecikowska J; Kubacka M; Siwek A; Bucki A; Pawłowski M; Bednarski M; Sapa J; Starek M; Dąbrowska M; Kołaczkowski M
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):536-545. PubMed ID: 29482394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New platelet aggregation inhibitors based on pyridazinone moiety.
    Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
    Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
    Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents.
    Ko TC; Hour MJ; Lien JC; Teng CM; Lee KH; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2001 Feb; 11(3):279-82. PubMed ID: 11212091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening.
    Bruno O; Schenone S; Ranise A; Bondavalli F; Barocelli E; Ballabeni V; Chiavarini M; Bertoni S; Tognolini M; Impicciatore M
    Bioorg Med Chem; 2001 Mar; 9(3):629-36. PubMed ID: 11310597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
    Liu XJ; Wang Y; Wang X; Zhang ZH
    Bioorg Med Chem; 2021 Sep; 46():116390. PubMed ID: 34500186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
    Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z
    Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.